CURRENTLY AVAILABLE NONINVASIVE TESTS ACCURATELY STAGE FIBROSIS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)

被引:0
|
作者
Harrison, Stephen A. [1 ]
Lawitz, Eric J. [2 ]
Wong, Vincent Wai-Sun [3 ]
Anstee, Quentin M. [4 ]
Trauner, Michael H. [5 ]
Romero-Gomez, Manuel [6 ]
Bhandari, Bal [7 ]
Abdelmalek, Manal F. [8 ]
Sanyal, Arun J. [9 ]
Patel, Keyur [10 ]
Leroy, Vincent [11 ]
Bureau, Christophe [12 ]
Sasso, Magali [13 ]
Fournier, Celine D. [13 ]
Sandrin, Laurent [13 ]
Han, Ling [14 ]
Li, Georgia [14 ]
Kersey, Kathryn [14 ]
Camargo, Marianne [14 ]
Djedjos, Stephen [14 ]
Myers, Robert P. [14 ]
Goodman, Zackary [15 ]
Younossi, Youssef [16 ]
机构
[1] Pinnacle Clin Res, San Antonio, TX USA
[2] Univ Texas Hlth San Antonio, Texas Liver Inst, San Antonio, TX USA
[3] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
[4] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England
[5] Med Univ Vienna, Div Gastroenterol & Hepatol, Vienna, Austria
[6] Univ Seville, Virgen Del Rocio Univ Hosp, Digest Dis Dept, Ciberehd,Seliver Grp,IBIS, Seville, Spain
[7] Delta Res Partners, Bastrop, LA USA
[8] Duke Univ, Durham, NC 27706 USA
[9] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[10] Univ Hlth Network, Toronto, ON, Canada
[11] Grenoble Univ Hosp, Hepatol Dept, Grenoble, France
[12] CHU Toulouse, Toulouse, France
[13] Echosens, Paris, France
[14] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[15] Inova Fairfax Hosp, Falls Church, VA USA
[16] Inova Hlth Syst, Falls Church, VA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2295
引用
收藏
页码:1349A / 1350A
页数:2
相关论文
共 50 条
  • [11] Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)
    Z. Wang
    Z. Zhao
    Y. Xia
    Z. Cai
    C. Wang
    Y. Shen
    R. Liu
    H. Qin
    J. Jia
    G. Yuan
    Journal of Endocrinological Investigation, 2022, 45 : 1379 - 1392
  • [12] Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)
    Wang, Z.
    Zhao, Z.
    Xia, Y.
    Cai, Z.
    Wang, C.
    Shen, Y.
    Liu, R.
    Qin, H.
    Jia, J.
    Yuan, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (07) : 1379 - 1392
  • [13] Serum markers of fibrogenesis and fibrosis in nonalcoholic steatohepatitis (NASH).
    Costanzo, M
    Miele, L
    Di Rocco, P
    Forgione, A
    Alfei, B
    Pompili, M
    Rapaccini, GL
    Grieco, A
    Gasbarrini, G
    HEPATOLOGY, 2002, 36 (04) : 412A - 412A
  • [14] Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis
    Caussy, Cyrielle
    Chuang, Jen-Chieh
    Billin, Andrew
    Hu, Tao
    Wang, Ya
    Subramanian, G. Mani
    Djedjos, C. Stephen
    Myers, Robert P.
    Dennis, Edward A.
    Loomba, Rohit
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [15] Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies
    Wattacheril, Julia
    Issa, Danny
    Sanyal, Arun
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58, 2018, 58 : 649 - 662
  • [16] Characterization of insulin resistance in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH)
    Ratziu, Vlad
    Sanyal, Arun J.
    Loomba, Rohit
    Caldwell, Stephen H.
    Ghalib, Reem H.
    Torres, Dawn M.
    McCullough, Arthur J.
    Muir, Andrew J.
    Myers, Robert P.
    Schall, Raul E. Aguilar
    Subramanian, Mani
    McHutchison, John G.
    Bosch, Jaime
    Harrison, Stephen A.
    Abdelmalek, Manal F.
    HEPATOLOGY, 2015, 62 : 1298A - 1299A
  • [17] Noninvasive Assessment of Nonalcoholic Steatohepatitis and Nonalcoholic Steatohepatitis-Related Fibrosis: Is There a Role for Cytokeratin 18?
    Xanthakos, Stavra A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 63 (02): : 167 - 168
  • [18] Comparing of noninvasive tests in predicting diagnosis of Nonalcoholic Steatohepatitis
    Braticevici, C. F.
    Alexandru, M.
    Tribus, L.
    Razvan, P.
    Ana, P.
    Necula, A.
    Radu, U.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S575 - S575
  • [19] The Role of Radiologic Modalities in Diagnosing Nonalcoholic Steatohepatitis (NASH) and Fibrosis
    Ralf Weiskirchen
    Frank Tacke
    Current Hepatology Reports, 2018, 17 (4) : 324 - 335
  • [20] Serum-Based Biomarker Accurately Stratifies Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis
    Abdelmalek, Manal F.
    Diehl, Anna Mae
    Guy, Cynthia D.
    Portenier, Dana
    Sudan, Ranjan
    Li, Xiaojun
    Mimms, Larry
    Jain, Anjali
    HEPATOLOGY, 2017, 66 : 55A - 56A